LSR
© [M] Munich Re [1] Shutterstock / Derexhopz

Munich Re at LUCID Conference 2025

19 - 20 May, Birmingham

    alt txt

    properties.trackTitle

    properties.trackSubtitle

    We're pleased to announce that Munich Re will be attending the LUCID conference, where our experts will share key findings from our latest Life Science Report. This report provides critical insights into emerging medical trends and risks that are transforming the Life and Health insurance industry.

    As medical breakthroughs and cutting-edge technological advances continue to shape the Life and Health insurance industry, our team at Munich Re is dedicated to staying at the forefront of these developments.

    A business guide on emerging medical trends and risks

    Our Life Science Report is a comprehensive guide to assessing both promises and pitfalls of emerging medical trends and risks, helping insurers better navigate the ever-evolving environment. With a focus on key areas of development, our report consists of five tailored chapters, exploring the topics of AI in Healthcare, Improving Cancer Outcomes, Prevention, Obesity and Climate Change.

     

     

    Watch our experts introduce the Life Science Report 2025

    Seizing the opportunities ​for prevention, diagnosis ​and treatment​

    Artificial Intelligence is transforming​ the healthcare landscape at an unprecedented pace. For life and health insurers, healthcare professionals, and patients alike, AI holds the promise of revolutionizing every single aspect of care – from earlier diagnoses to personalized treatment options. Insurers will need to leverage cutting-edge medical expertise and stay ahead of evolving trends to navigate this transformative landscape successfully.

    Monitoring advances in cancer research and treatment

    Although still the leading cause of death among policyholders, cancer is increasingly becoming a manageable disease, reshaping the entire insurance landscape. The rise of personalized medicine and AI-driven diagnostics is revolutionizing how we prevent, detect, and treat cancer. As medical research continues to advance in this field, it is crucial for life and health insurers to closely monitor the implications for insurance products and healthcare costs.

    Addressing the root causes of mortality and morbidity

    A strategic shift from a reactive approach of settling claims to actively improving lives can make a lasting impact on both policyholders and society. By prioritizing prevention and leveraging data-driven insights, life and health insurers reach a wider audience and enhance health literacy among policyholders, transforming the industry towards proactive health management. 

    Quantifying the impact of newer drugs to reverse the upward obesity trend

    By 2035, more than half of the global population is predicted to be overweight or obese, posing substantial challenges for insurers, policymakers, and healthcare providers. Newer obesity medications offer promising weight loss outcomes, having the potential to reduce morbidity and mortality rates. Insurers need to stay ahead of the curve in understanding the impact of newer treatments on insurance portfolios and develop effective strategies for managing obesity-related risks. 

    Localising the impact of a looming health risk with high uncertainties

    Climate change represents a significant and complex challenge for humanity, with the potential to affect human health in numerous ways. The impact of climate-related risks, including natural disasters and emerging infectious diseases, can influence mortality and morbidity rates. However, the effects of these risks are not yet fully understood, with considerable uncertainty across regions. To maintain resilience and effectively manage these risks, life and health insurers must gain a deeper understanding of the potential implications for underwriting, portfolio management and claims.

    Highlights at LUCID Conference 2025

    LUCID Conference has been running 12 years. Considered a key calendar event for financial services industry, particularly underwriting and claims, you will hear from leading medical and industry experts, both with current relevance as well as future innovations. 
    8:00 AM - 9:30 AM Registration & Exhibition
    9:30 AM - 11:15 AM Sessions including Dr Kevin Somerville Keynote
    11:15 AM - 11:45 AM AM Break & Exhibition
    11:45 AM - 1:15 PM Morning Sessions Day 1
    1:15 PM - 2:15 PM Lunch & Exhibition
    2:15 PM - 4:00 PM Afternoon Sessions Day 1
    4:00 PM - 4:30 PM PM Break & Exhibition
    4:30 PM - 5:15 PM Late Afternoon Sessions Day 1
    7:00 PM - 12:00 AM LUCID Masquerade
    8:00 AM - 8:45 AM Registration & Exhibition Day 2
    8:45 AM - 10:35 AM Sessions including Calvin Cole Keynote
    10:35 AM - 11:15 AM AM Break & Exhibition Day 2
    11:15 AM - 12:15 PM Morning Sessions Day 2
    12:15 PM - 1:15 PM Lunch & Exhibition Day 2
    1:15 PM - 2:30 PM Afternoon Sessions Day 2
    2:30 PM - 3:00 PM PM Break & Exhibition Day 2
    3:00 PM - 4:30 PM Late Afternoon Sessions Day 2

    Further information

    Contacts

    Matt Bone
    Matthew Bone
    Head of Underwriting and Claims
    Angela Gaviria
    Angela Gaviria
    Underwriting & Claims Strategy Manager
    Claims Proposition Manager
    Sean Grainger
    Claims Proposition Manager
    Development Underwriter Manager
    Lloyd Williams
    Development Underwriter Manager